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Although metastases within the thyroid gland are rare, they are not as infrequent as gener-
ally believed.Asymptomatic breast, lung, and renal cell carcinomas may metastasize to the
thyroid. When they become symptomatic, diagnosis relies upon fine needle aspiration cy-
tology. We report the case of a squamous cell cervical cancer that presented metastatic le-
sions to the thyroid gland four years after the initial diagnosis. The procedures used to
confirm the diagnosis, stage, and subsequently manage the patient are described. We pres-
ent both a review of the necessary clinical investigation and the therapeutic options open to
these patients. We conclude that patients who present swelling or palpable nodules in the
thyroid side and have a history of a previous malignancy must be considered for metastatic
disease.
INTRODUCTION
Metastases to the thyroid gland have
been described as early as the 1930s [1].
Since then, several reports have demon-
strated a discrepancy in the incidence, de-
pending on the perseverance with which
the thyroid nodules were investigated. In
general, it is estimated that only 1.1 percent
of all clinically detectable thyroid cancers
are of metastatic origin [2]. Nevertheless, a
single post-mortem study suggests that sec-
ondary tumors in the thyroid gland might
be up to 10 times as common as primary
thyroid cancer [3]. Other autopsy studies
describe thyroid metastatic lesions in as
many as 24 percent of patients with dissem-
inated disease; although in most cases,
there is no evidence of clinical manifesta-
tions from thyroid infiltration [4]. With re-
gard to the origin of the metastatic thyroid
lesions, the most common primary sites are
cancers of the kidney, breast, lung, and gas-
trointestinal system, and melanoma. The
mean interval from the diagnosis of the pri-
mary tumor to the development of the thy-
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†Abbreviations: FNAC, fine needle aspiration cytology.roid metastasis is 14 months, the range vary-
ing according to the histological type [5].
We present the case of a patient with cervi-
cal carcinoma who developed thyroid
metastases four years after the curative treat-
ment of the primary tumor.
CASE REPORT
A 68-year-old woman was admitted to
our department after complaining of a per-
sistent cough over the course of a week, he-
moptysis, and a temperature that would peak
at 37.8°C (100°F) over the last two months.
She had noticed a painless swelling in the
region of the thyroid gland and a palpable
mass in the right side of her neck. Four years
ago, the patient had been diagnosed with
squamous cell carcinoma of the cervix stage
ʙʙʙʒ, moderately differentiated, for which
she had received external beam radiotherapy
to the pelvis and brachytherapy.
Upon physical examination, an irregu-
lar, hard-fixed mass measuring 8.6 cm was
felt in the right lateral region of the neck,
along with a firm thyroid enlargement.
Chest auscultation revealed altered breath
sounds in the left lung, with rales and
rhonchi. Her blood cell count and serum bio-
chemistry were normal, and the rate of sed-
imentation was 65mm the first hour. The
patient underwent a CT scan of the neck,
thorax, abdomen, and pelvis that revealed a
large irregular mass 9 cm in diameter in the
right lateral region of the neck, enlargement
of the thyroid gland, enlarged mediastinal
and paraaortic nodes, and multiple patchy
airspace infiltrates, without evidence of local
recurrence. A bone scan was negative for
metastases. Fiberoptic bronchoscopy re-
vealed edematous and erythematous mucosa
of the upper bronchus of the right lower lobe
and erythematous edematous mucosa with
probable subserosa infiltration of the lingual
bronchus. Sputum cytology after bron-
choscopy washing and brushing was posi-
tive for undifferentiated carcinoma. Since
the cytology report could not establish a def-
inite diagnosis, a biopsy of the thyroid gland
was performed, which showed non-kera-
tinizing squamous cell carcinoma compati-
ble with primary squamous cell carcinoma
of the cervix. The pathologist also reviewed
slides of the cervical biopsy from four years
previous and confirmed that the thyroid
tumor was histologically identical to the ini-
tially documented cervical carcinoma.
The patient received six cycles of sys-
tematic chemotherapy with cisplatin and
gemcitabine, with partial response. Subse-
quently, she received radiation therapy to the
right side of the neck and the thyroid, with
further decrease of the lymph nodes and thy-
roid mass. Five months after the completion
of radiotherapy, the patient developed pro-
gressive disease and succumbed four
months later. The overall survival after di-
agnosis of the thyroid metastasis was 16
months.
DISCUSSION
Metastases to the thyroid may occur
with high frequency in patients with wide-
spread metastatic lesions. When the thyroid
lesions become symptomatic, patients usu-
ally present with thyroid enlargement and
palpable nodules, cough, hoarseness, dys-
phagia, and dyspnea.Thyroid implication to
other solid malignancies may arise either by
direct spread from adjacent tissues or by
lymphatic and hematogenous spread, which
is not surprising, considering the thyroid
gland is one of body’s most abundantly arte-
rialized organs [6].
Up to 70 percent of patients with cervi-
cal cancer who present nodal metastases
and/or locally advanced disease will relapse.
Cervical cancer gives distant metastases via
the lymphatic spread, from the satellite
nodes to the paraaortic and supraclavicular
nodes. The route of the hematogenous
spread is presumed to occur via the blood
stream to the caval venous system through
the lung parenchyma and systematic circula-
tion. In patients who develop distant metas-
tases, the most frequently observed
metastatic sites are the lung (21 percent), the
para-aortic lymph nodes (11 percent), the
abdominal cavity (8 percent), and the supr-
aclavicular lymph nodes (7 percent). Bone
metastases occur in only 16 percent of pa-
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gland from cancer of the cervix is very rare.
Upon reviewing the English literature, only
five cases of cervical carcinoma are de-
scribed as having metastasized to the thyroid
gland [7-11].
The involvement of the thyroid gland
usually becomes apparent some years after
the diagnosis of the primary malignancy and
is a feature of tumor dissemination, which is
indicative of a poor prognosis. In the context
of widespread metastatic disease, the clini-
cal manifestation of thyroid lesions is usu-
ally of no importance. In fact, surgical
statistics reveal that lesions of metastatic ori-
gin represent only 8.5 percent of all removed
malignant neoplasms. It is unknown whether
secondary tumors of the thyroid are more
common in an already abnormal thyroid
gland. Two studies have been performed
with contradictory results as one group of re-
searchers maintains that thyroid metastases
are associated with underlying thyroid ab-
normalities, while the other failed to estab-
lish such a correlation [12,13].
Explaining the nature of thyroid nod-
ules (whether malignant or benign) can be-
come a difficult diagnostic task, especially
if they occur many years after the initial
tumor.Adifferential diagnosis must be made
of multinodular goiter and benign thyroid
nodules. If the malignant phenotype is con-
firmed, it must be clarified as to whether it is
a primary or secondary neoplastic lesion.
Since both entities have the same clinical
signs and symptoms (if any), diagnosis re-
lies upon fine needle aspiration cytology
(FNAC)†, a simple, inexpensive, and safe
procedure with high negative diagnostic
value. In most cases, confirming the cyto-
logical origin of the neoplastic cells can be
based on morphology and immunocyto-
chemical staining; negative staining with
anti-thyroglobulin and anti-calcitonin anti-
bodies would exclude the thyroid as primary
origin of the neoplastic cells. On the con-
trary, thyroid follicular neoplasms tend to
maintain some cytoplasmic granularity and,
as a result, usually stain positively for thy-
roglobulin. In the pathology examination,
the presence of multiple deposits within the
thyroid gland makes the diagnosis of a
metastatic tumor more probable. Further-
more, a predominantly interstitial pattern of
penetration, with deformation and dissemi-
nation of the follicles by the neoplastic cells,
is more compatible with metastatic origin of
the carcinogenic cells. On the contrary, pri-
mary thyroid neoplasms usually infiltrate the
follicles. Despite all the above techniques,
occasionally it may be difficult to determine
from cytology whether the neoplastic cells
originate from the thyroid gland, especially
in cases of anaplastic carcinoma or the un-
usual clear cell variant of follicular carci-
noma. In any case, diagnostic re-evaluation
of the primary tumor and search for other
metastatic sites are mandatory to establish
metastatic derivation of thyroid nodules
[14,15].
The management of patients with
metastatic thyroid lesions is determined by
the primary tumor type, the presence of
other metastatic sites, the patient’s symp-
toms and the patient’s performance status.
Aggressive surgical treatment of an isolated
thyroid metastasis, which is most often from
renal cell carcinoma, could be curative. The
regional application of radiotherapy in
symptomatic patients may achieve sufficient
improvement of the quality of life and con-
stitutes an acceptable alternative approach.
Finally, the location of other metastatic sites
will determine the manner of systemic man-
agement. Since the presence of metastases
in the thyroid gland is indicative of dissem-
inated disease, the prognosis of these pa-
tients is poor, regardless of the primary
tumor site and therapeutic approaches. The
time between presentation of thyroid metas-
tasis and death ranged from three to 45
months in one study of 79 patients [16].
In conclusion, patients who present uni-
lateral swelling or palpable nodules in the
thyroid and have a history of a previous ma-
lignancy must be considered for metastatic
disease, despite the fact that in most cases
thyroid lesions are occult and do not pose a
clinical problem. FNAC provides a quick,
easy, and reliable way of diagnosis, while
biopsy of the lesion and histopathological
examination is the most appropriate tool for
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metastases to the thyroid gland is often in-
dicative of a poor prognosis, aggressive
medical treatment such as radiotherapy and
systemic chemotherapy may be effective in
offering a better quality of life.
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